Friday 6 November 2026 Export SNN’s income statement to Excel — free account

Smith & Nephew SNATS, Inc.

Smith & Nephew SNATS, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, up 6.09% from fiscal 2024.

31.14 0.87 −2.72%

Follow SNN

Alert me

Market cap: $13.4B
P/E: 38.9×
Fwd P/E: 18.9×
Dividend yield: 2.49%
F-score: 7/9
Altman Z: 3.49
Beneish M: −2.70
Dividend safety: 61/100

Overview

Smith & Nephew SNATS, Inc. (SNN) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Smith & Nephew SNATS, Inc. (SNN) trades at a price to free cash flow of 7.1×. Over the past ten years it has ranged from 5.9× (October 2026) to 53.8× (March 2015); the current reading is higher than 3% of that period. That is below the Medical Devices industry median of 28.8× and below the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/SNN/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Smith &amp; Nephew SNATS, Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/SNN/metrics/price-to-free-cash-flow">Smith &amp; Nephew SNATS, Inc. (SNN) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	8.1×	(41.75%)
FY2024	13.8×	(68.95%)
FY2023	44.5×	190.81%
FY2022	15.3×	1.76%
FY2021	15.0×	13.93%
FY2020	13.2×	7.66%
FY2019	12.3×	16.11%
FY2018	10.6×	35.80%
FY2017	7.8×	(5.22%)
FY2016	8.2×	(44.80%)

Period	Price to free cash flow	Change
Jun 2023	25.1×	69.34%
Dec 2022	14.8×	43.37%
Jun 2022	10.3×	(29.67%)
Dec 2021	14.7×	2.36%
6 more quarters	Free account

Against its own ten years

Low 5.9× High 53.8×

Ten-year median 12.5×

Current reading's percentile 3

Company	Price to free cash flow
SNN Smith & Nephew SNATS, Inc.	7.1×
GMED Globus Medical, Inc. compare	14.5×
BIO Bio-Rad Laboratories, Inc. compare	30.0×
BIO.B Bio-Rad Laboratories, Inc. compare	30.7×
BRKR Bruker Corporation compare	32.9×
PODD Insulet Corporation compare	46.4×
PEN Penumbra, Inc. compare	63.1×
TXG 10x Genomics compare	63.3×
GKOS Glaukos Corporation compare	360×
Medical Devices industry median	28.8×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Smith & Nephew SNATS, Inc. (SNN) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on SNN

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on SNN

Stockrow Weekly